CSF proteomic study of Alzheimer's Disease

ABSTRACT: TMT Proteomic study of CSF from patients with Alzheimer's disease, non-cognitively impaired controls, and subjects with mild or subjective cognitive impairment

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cerebrospinal Fluid

DISEASE(S): Alzheimer's Disease 10

SUBMITTER: Johan Gobom  

LAB HEAD: Johan Gobom

PROVIDER: PXD019910 | Pride | 2020-12-04

REPOSITORIES: Pride